Company: BKYI
Filing Date: 2025-04-24
Form Type: 8-K
Source: 0001437749-25-012986
Chunk: 0

Company: BIO KEY INTERNATIONAL INC
Filing Date: 2025-04-24
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item 3.01.

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On April 17, 2025, BIO-key International, Inc. (the “ Company”) received notice from The Nasdaq Stock Market, LLC (“ Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (“ SEC”), due to the Company’s failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2024 (the “Form 10-K”). The notification letter has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market.

On April 23, 2025, the Company filed the Form 10-K with the SEC. On April 24, 2025, the Company received notice from Nasdaq stating that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1) and that the matter has been closed.

Item 7.01. Regulation FD Disclosure.

On April 24, 2025, the Company issued a press release regarding the matters described in Item 3.01 of this Form 8-K. A copy of the press release is attached to this Form 8-K as Exhibit 99.1 and incorporated herein by reference.

In accordance with General Instruction B.2 of Form 8-K, the information furnished under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such a filing.

Item 9.01Financial Statements and Exhibits.